Anuja Jaiswal · DistrictNews · 2026-08-20
Personalised cancer vaccine takes step closer to market
NEW DELHI: A personalised cancer vaccine has shown encouraging results in a large Phase-3 trial of patients with high-risk melanoma - a potentially aggressive form of skin cancer - helping keep the cancer from returning or spreading when given along with Merck's immunotherapy Keytruda, pharma major ... NEW DELHI: A personalised cancer vaccine has shown encouraging results in a large Phase-3 trial of patients with high-risk melanoma - a potentially
Read original on Anuja Jaiswal Get the app
Licensed summary · LicensedSummary
Related briefs
- FPIs turn bullish on financials, autos and IT in first half of August
- 'Awarapan 2' box office collection Day 7: Emraan Hashmi starrer wraps up first week with solid Rs 113 crore, is a hit with 151 percent ROI
- Indian National On FBI's Most Wanted' List Over Lawrence Bishnoi Gang Links
- India weighs facilitating European, UK investments via green channel
- Delhi Boosts Women's Safety With More Police Near Colleges, Transit Hubs